Efren, Rhaizel Quin M.
HRN: 21-33-16 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/17/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/17/2022
05/26/2022
IVT
70mg
TID
Infectious Diarrhea
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes